EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety

NCT01834768 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Insufficiency
Kidney Transplantation

Interventions

DRUG: Eplerenone

Sponsor

CHU de Reims

Collaborators

[object Object]